PureTech Health (PRTC) Debt to Equity (2020 - 2023)
PureTech Health (PRTC) has disclosed Debt to Equity for 4 consecutive years, with $0.03 as the latest value for Q4 2023.
- For Q4 2023, Debt to Equity rose 250.02% year-over-year to $0.03; the TTM value through Dec 2023 reached $0.03, up 250.02%, while the annual FY2023 figure was $0.03, 250.02% up from the prior year.
- Debt to Equity hit $0.03 in Q4 2023 for PureTech Health, up from $0.01 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.03 in Q4 2023 and bottomed at $0.01 in Q4 2022.
- Average Debt to Equity over 4 years is $0.02, with a median of $0.02 recorded in 2021.
- Year-over-year, Debt to Equity tumbled 62.67% in 2022 and then surged 250.02% in 2023.
- PureTech Health's Debt to Equity stood at $0.02 in 2020, then increased by 15.13% to $0.03 in 2021, then plummeted by 62.67% to $0.01 in 2022, then soared by 250.02% to $0.03 in 2023.
- According to Business Quant data, Debt to Equity over the past three periods came in at $0.03, $0.01, and $0.03 for Q4 2023, Q4 2022, and Q4 2021 respectively.